ArticleFrontiers in immunology2023

Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation.

Matthias Schaier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.